VVT Medical specializes in the research, development, manufacturing and commercialization of minimally invasive, non-thermal non-tumescent- NT-NT solutions for the treatment of varicose veins.
VVT Medical’s advanced, proprietary solutions combine best practices in vein treatment with a powerful, patented delivery system to provide a simpler, more effective approach to treatment. Our flagship ScleroSafe platform enables physicians to perform quick, office-based procedures without the need for tumescent anesthesia or costly capital equipment. VVT Medical’s solutions can be performed in a range of outpatient settings including vein clinics, day care clinics, angio suites, catheterization laboratories and hospitals.
For over 10 years, VVT Medical has been dedicated to offering simpler, faster and more efficient minimally-invasive surgical procedures, maximizing safety and patient comfort and achieving superior clinical results.
VVT Medical was founded in 2007 with the vision to offer superior treatment options to patients suffering from varicose veins, venous valve incompetence and reflux disease. Our focus on innovation is central to everything we do in our efforts to address the pain, costs and recovery time usually associated with conventional treatment. We aspire to offer the best treatment options possible to physicians and their patients.
VVT Medical’s leadership team brings together years of experience in management, R&D, product development, engineering and medical regulatory expertise across the medical device, high tech, biotech, healthcare and medical imaging industries.